ESR1 and breast cancer: To test whether EMP favored the metastatic spread of ER+ BC cells early in tumor progression, we induced EMP by reducing CDH1 expression or by overexpressing ZEB1. Given the heterogeneity of the lentivirally transduced polyclonal cell populations, we expected that a whole spectrum of EMP states would be produced.